Stefan Kasper
Goethe University Frankfurt(DE)Allen Institute for Brain Science(US)Klinik und Poliklinik für Urologie(DE)West Cancer Center(US)National Center for Tumor Diseases(DE)Essen University Hospital(DE)West German Heart and Vascular Center Essen(DE)Deutschen Konsortium für Translationale Krebsforschung(DE)University of Duisburg-Essen(DE)Social Care Institute for Excellence(GB)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Cholangiocarcinoma and Gallbladder Cancer Studies, Gastric Cancer Management and Outcomes
Most-Cited Works
- → Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck(2016)4,969 cited
- → Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial(2019)2,483 cited
- → Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression(2018)786 cited
- → Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial(2017)421 cited
- → Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study(2023)292 cited